← Eichor
Study identifier: NCT06537609 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Platform Trial for Gram Negative Bloodstream Infections

Condition: Gram-negative Bacteremia  ·  Sponsor: Sunnybrook Health Sciences Centre

PhaseNA
Planned participants2500
Who can joinAll sexes, 0 Years to 130 Years
Healthy volunteersNo

About this study

BALANCE+ is a perpetual multiple domain randomized controlled platform trial to evaluate various treatment strategies for Gram-negative bloodstream infections (GN BSIs). Each domain addresses critical questions in the management of GN BSIs, aiming to refine treatment strategies, enhance patient outcomes, and reduce antimicrobial resistance. The initial vanguard pilot RCT (NCT05893147) started on 29 August 2023 and has successfully completed the pilot phase on 24-Apr-2024. All patients enrolled in the vanguard phase are part of the main platform trial.

This description comes directly from the study's public registry record.

Talk to the study team

Nick Daneman, MD  ·  4164806100  ·  nick.daneman@sunnybrook.ca

Mithun Mohan George  ·  416-480-6100  ·  mithun.george@sri.utoronto.ca

Always discuss trial participation with your own doctor first.

Locations (39)

St George HospitalKogarah, New South Wales, AustraliaRecruiting
John Hunter HospitalNew Lambton, New South Wales, AustraliaRecruiting
Royal Brisbane and Women's HospitalHerston, Queensland, AustraliaRecruiting
Redcliffe HospitalRedcliffe, Queensland, AustraliaRecruiting
Sunshine Coast University HospitalSunshine Coast, Queensland, AustraliaRecruiting
Monash Medical CenterClayton, Victoria, AustraliaRecruiting
Fiona Stanley HospitalMurdoch, Western Australia, AustraliaRecruiting
St John of GodMurdoch, Western Australia, AustraliaRecruiting
Foothills HospitalCalgary, Alberta, CanadaRecruiting
Peter Lougheed CentreCalgary, Alberta, CanadaRecruiting
Rockyview General HospitalCalgary, Alberta, CanadaRecruiting
South Health CampusCalgary, Alberta, CanadaRecruiting

+ 27 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06537609